ANDA 83901, held by Lannett. Amphetamine Sulfate.
As of Nov 16, 2026, ANDA 83901 (Amphetamine Sulfate), held by Lannett, was first approved by FDA on Aug 31, 1984, with 6 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 1984 | Original application | Approved | None posted |
| Amphetamine Sulfate5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet;oral | Amphetamine Sulfate | DiscontinuedReference drug |
| Amphetamine Sulfate10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet;oral | Amphetamine Sulfate | DiscontinuedReference drug |
| Oct 13, 2023 | Supplement 7Labeling · Standard review | Approved | None posted |
| Feb 25, 2022 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jan 4, 2017 | Supplement 4Labeling · Standard review | Approved | None posted |
| Apr 17, 2015 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jun 17, 1991 | Supplement 2Labeling | Approved | None posted |
| Jun 5, 1987 | Supplement 1Manufacturing | Approved | None posted |
| Aug 31, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters